• Home
  • NEW DAY MEDICINE
  • 9 (47) 2022
  • 74 — 9 (47) 2022 — Ismatova M.N., Ashurov F.Z., THE ROLE OF LABORATORY PARAMETERS IN COVID-19 AS A PREDICTOR OF SEVERITY

74 — 9 (47) 2022 — Ismatova M.N., Ashurov F.Z., THE ROLE OF LABORATORY PARAMETERS IN COVID-19 AS A PREDICTOR OF SEVERITY

THE ROLE OF LABORATORY PARAMETERS IN COVID-19 AS A PREDICTOR OF SEVERITY

Ismatova M.N., Bukhara State Medical Institute

Ashurov F.Z., Bukhara State Medical Institute

Resume

In the context of the COVID-19 pandemic that is developing every day, doctors need methods that can accurately assess the severity of the disease, predictors, and the effectiveness of treatment. These tools should not only have high sensitivity and specificity, but also be affordable, economical and easy to use. The article discusses the scientific work of regional and foreign researchers on the relationship between the severity of the course of coronavirus infection and laboratory blood tests.

Key words: Coronavirus infection, laboratory tests, complete blood tests, severity of COVID-19

First page

441

Last page

443

For citation: Ismatova M.N., Ashurov F.Z., THE ROLE OF LABORATORY PARAMETERS IN COVID-19 AS A PREDICTOR OF SEVERITY //New Day in Medicine 9 (47)2022 441-443 https://l.clck.bar/7d444

LIST OF REFERENCES:

  1. Mareev V. Yu., Begrambekova Yu.L., Mareev Yu.V. Yangi koronavirus infeksiyasi (covid-19) bilan kasallangan bemorlarni davolash natijalarini qanday baholash mumkin? Klinik holatni baholash shkalasi (SHOX-COVID). // Kardiologiya. 2020; 60(11):35–41. DOI: 10.18087/kardio.2020.11.n1439
  2. Liao X., Vang B., Kang Y. 2019–2020 epidemiyasi davrida yangi koronavirus infektsiyasi: intensiv terapiya bo’limlarini tayyorlash – Xitoyning Sichuan provinsiyasidagi tajriba. // Intensiv terapiya. 2020; 46(2):357–360. DOI:10.1007/s00134-020- 05954-2.
  3. Mareev V.Y., Orlova Y.A., Pavlikova E.P., Matskeplishvili S.T., Krasnova T.N., Malahov P.S. va boshqalar. Koronavirusli pnevmoniya (COVID-19), tizimli yallig’lanish va venoz tromboz va tromboemboliya xavfi bo’lgan bemorlarda steroid puls terapiyasi (WAYFARER tadqiqoti). kardiologiya. 2020; 60(6):15–29. DOI:10.18087/kardio.2020.6.n1226.
  4. Genri B.M., de Oliveyra M.H., Benoit S., Plebani M., Lippi G. Koronavirus kasalligi 2019 (COVID-19) da og’ir kasallik va o’lim bilan bog’liq gematologik, biokimyoviy va immun biomarker anormalliklari: meta-tahlil. // Klinik kimyo va laboratoriya tibbiyoti. 2020; 58(7):1021–1028. DOI:10.1515/cclm-2020-0369
  5. Ismatova M.N., Mukhamedjanova M.Kh., Ashurov F.Z. Structural changes of the respiratory organs due to covid-19 disease // New Day in Medicine 5(43)2022 262-267 https://clck.ru/nerDW
  6. Lippi G., Plebani M., Genri BM Trombotsitopeniya og’ir koronavirus kasalligi 2019 (COVID-19) infektsiyalari bilan bog’liq: meta-tahlil. Clinica chimica acta. 2020; 506:145-148. DOI:10.1016/j.cca.2020.03.022
  7. Lippi G., Plebani M. Prokalsitonin og’ir koronavirus kasalligi 2019 (COVID-19): Metaanalisis. Clinica chimica acta. 2020;505:190–191. DOI:10.1016/j. taxminan 2020.03.004
  8. Genri B.M. COVID-19, ECMO va limfopeniya: ehtiyot so’zi. Lancet. // Nafas olish tibbiyoti. 2020; 8(4): e24. DOI:10.1016/S2213-2600(20)30119-3
  9. Alcaíno H., Pozo J., Pavez M., Toledo H. Ancho de distribución eritrocitaria como potentsial biomarkador klinikasi va enfermedades cardiovasculares. // Revista medica de Chili. 2016; 144(5):634–642. DOI:10.4067/S0034- 98872016000500012
  10. Mukhammedjanova M.H. Anemia in patients with interferences and interpretation of modern therapy // New Day in Medicine 4(36)2021 150-152 https://cutt.ly/TTnIRjv